Status:
COMPLETED
Exposure Measurements and Interventions for Aerosol Produced by Gastrointestinal Endoscopy
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Tsinghua University
Conditions:
Droplet Transmission
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Study objective: To clarify the risk of exposure to the exhaled aerosol droplets from patients for medical staffs during digestive endoscopy via labelling the oral mucosa with vitamin B2 solution, and...
Detailed Description
This is a prospective randomized controlled study. Patients who meet the inclusion criteria and do not meet the exclusion criteria are recruited for this trial. They will be randomly divided into the ...
Eligibility Criteria
Inclusion
- During the study period, patients who were treated in the digestive endoscopy center of Peking Union Medical College Hospital and planned to undergo digestive endoscopy. Age and gender are not limited temporarily.
Exclusion
- Patients who have ever been allergic to the medical non-toxic fluorescent agent ( vitamin B2 saline solution).
- Patients who received anti-tumor therapy during the period of digestive endoscopy.
- Patients with poor general conditions, including severe cardiopulmonary diseases, coagulation disorders, or a total of platelet less than 50\*10\^9/L.
- Patients with structural pulmonary disease (chronic obstructive pulmonary disease, asthma, etc.) or airway/pulmonary surgery history
- Patients with intolerance or contraindications to digestive endoscopy.
Key Trial Info
Start Date :
June 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05321056
Start Date
June 17 2022
End Date
December 1 2024
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, China, 100730